TLR4 and Parkinson disease: FMT treatment inhibited the expression of p-PI3K, p-AKT, TLR4, and NF-κB, as well as TNF-α, confirming a close link between the TLR4/PI3K/AKT/NF-κB signaling and gut microbial dysbiosis in PD (158).